| Health / Medical Topics |
Sonepcizumab
A humanized monoclonal antibody directed against sphingosine 1-phosphate (S1P) with potential antiangiogenic and antineoplastic activities. Upon administration, sonepcizumab binds S1P, which may result in the inhibition of tumor angiogenesis. S1P is the extracellular ligand for the G protein-coupled lysophospholipid receptor EDG-1 (endothelial differentiation gene-1). (NCI Thesaurus)
YOU MAY ALSO LIKE
The husband of your daughter.
A male human offspring.
Periods of drowsiness, lethargy, loss of appetite, and irritability in children following radiation therapy treatments to the head.
A sleep disorder characterized by excessive sleepiness and drowsiness.
A response indicating that an individual has been somewhat more socially active than before.
A response indicating that an individual feels somewhat more limited than others.
